Steven J. Kirincich

Structure-Based Optimization of Protein Tyrosine Phosphatase 1B Inhibitors:  From the Active Site to the Second Phosphotyrosine Binding Site

Douglas Wilson, Zhao‐Kui Wan, Weixin Xu et al. · Journal of Medicinal Chemistry · 2007 · 156 citations · Full text

Proteinlipid Interaction, Drug Target, Molecular Biology +18

Molecular activation of PPARγ by angiotensin II type 1-receptor antagonists

David V. Erbe, Katherine Gartrell, Yanling Zhang et al. · Vascular Pharmacology · 2006 · 136 citations

Molecular Pharmacology, Signal Transduction, Molecular Physiology +11

Indole Cytosolic Phospholipase A₂α Inhibitors: Discovery and in Vitro and in Vivo Characterization of 4-{3-[5-Chloro-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino}ethyl)-1-(diphenylmethyl)-1<i>H</i>-indol-3-yl]propyl}benzoic Acid, Efipladib

John C. McKew, Katherine L. Lee, Marina W. H. Shen et al. · Journal of Medicinal Chemistry · 2008 · 88 citations

An Aldol Approach to the Synthesis of the EF Fragment of Spongistatin 1

Michael T. Crimmins, Jason D. Katz, Laura C. McAtee et al. · Organic Letters · 2001 · 45 citations

An Improved Synthetic Preparation of 3-Butenal

Michael T. Crimmins, Steven J. Kirincich, Angela J. Wells et al. · Synthetic Communications · 1998 · 45 citations

Aqueous Glyoxal, Multigram Quantities, Organic Chemistry +7